International Association for the Study of Lung Cancer

Publications in OpenAlex of which a co-author is affiliated to this organization

All publications | By field | By subfield

All publications [Next]
Title DOI
https://doi.org/10.1016/s0140-6736(16)30958-8 Lung cancer: current therapies and new targeted treatments
https://doi.org/10.1016/j.jtho.2016.11.2228 PD-L1 Immunohistochemistry Assays for Lung Cancer: Results from Phase 1 of the Blueprint PD-L1 IHC Assay Comparison Project
https://doi.org/10.5858/arpa.2017-0388-cp Updated Molecular Testing Guideline for the Selection of Lung Cancer Patients for Treatment With Targeted Tyrosine Kinase Inhibitors: Guideline From the College of American Pathologists, the International Association for the Study of Lung Cancer, and the Association for Molecular Pathology
https://doi.org/10.1016/j.jtho.2018.05.013 PD-L1 Immunohistochemistry Comparability Study in Real-Life Clinical Samples: Results of Blueprint Phase 2 Project
https://doi.org/10.1016/j.jtho.2018.05.030 Liquid Biopsy for Advanced Non-Small Cell Lung Cancer (NSCLC): A Statement Paper from the IASLC
https://doi.org/10.1016/j.jtho.2017.12.001 Updated Molecular Testing Guideline for the Selection of Lung Cancer Patients for Treatment With Targeted Tyrosine Kinase Inhibitors
https://doi.org/10.1016/j.jtho.2021.06.017 Liquid Biopsy for Advanced NSCLC: A Consensus Statement From the International Association for the Study of Lung Cancer
https://doi.org/10.1016/j.jtho.2020.06.001 A Grading System for Invasive Pulmonary Adenocarcinoma: A Proposal From the International Association for the Study of Lung Cancer Pathology Committee
https://doi.org/10.1097/jto.0b013e31815e6d6b Primary Tumor Standardized Uptake Value (SUVmax) Measured on Fluorodeoxyglucose Positron Emission Tomography (FDG-PET) is of Prognostic Value for Survival in Non-small Cell Lung Cancer (NSCLC): A Systematic Review and Meta-Analysis (MA) by the European Lung Cancer Working Party for the IASLC Lung Cancer Staging Project
https://doi.org/10.1016/s0140-6736(16)31473-8 New and emerging targeted treatments in advanced non-small-cell lung cancer
https://doi.org/10.1016/j.jmoldx.2017.11.004 Updated Molecular Testing Guideline for the Selection of Lung Cancer Patients for Treatment With Targeted Tyrosine Kinase Inhibitors
https://doi.org/10.1016/j.jtho.2019.12.107 PD-L1 Testing for Lung Cancer in 2019: Perspective From the IASLC Pathology Committee
https://doi.org/10.1016/j.jtho.2020.05.019 The Promises and Challenges of Tumor Mutation Burden as an Immunotherapy Biomarker: A Perspective from the International Association for the Study of Lung Cancer Pathology Committee
https://doi.org/10.1016/j.jtho.2016.03.012 Scientific Advances in Lung Cancer 2015
https://doi.org/10.1016/j.jtho.2016.05.008 The International Association for the Study of Lung Cancer Consensus Statement on Optimizing Management of EGFR Mutation–Positive Non–Small Cell Lung Cancer: Status in 2016
https://doi.org/10.1016/j.jtho.2022.09.109 Predictive Biomarkers for Immunotherapy in Lung Cancer: Perspective From the International Association for the Study of Lung Cancer Pathology Committee
https://doi.org/10.1016/j.jtho.2018.09.017 Current Status and Future Perspectives on Neoadjuvant Therapy in Lung Cancer
https://doi.org/10.1016/j.jtho.2020.05.002 The International Association for the Study of Lung Cancer Global Survey on Molecular Testing in Lung Cancer
https://doi.org/10.1016/j.jtho.2016.01.012 Small Cell Lung Cancer: Can Recent Advances in Biology and Molecular Biology Be Translated into Improved Outcomes?
https://doi.org/10.1016/j.jtho.2020.01.016 New Approaches to SCLC Therapy: From the Laboratory to the Clinic
https://doi.org/10.1016/j.jtho.2023.05.024 Air Pollution and Lung Cancer: A Review by International Association for the Study of Lung Cancer Early Detection and Screening Committee
https://doi.org/10.1016/j.jtho.2018.08.2036 Current and Future Management of Malignant Mesothelioma: A Consensus Report from the National Cancer Institute Thoracic Malignancy Steering Committee, International Association for the Study of Lung Cancer, and Mesothelioma Applied Research Foundation
https://doi.org/10.1016/j.jtho.2018.06.011 Scientific Advances and New Frontiers in Mesothelioma Therapeutics
https://doi.org/10.1016/j.jtho.2024.06.010 Neoadjuvant and Adjuvant Treatments for Early Stage Resectable NSCLC: Consensus Recommendations From the International Association for the Study of Lung Cancer
https://doi.org/10.1016/j.jtho.2020.05.001 Treatment Guidance for Patients With Lung Cancer During the Coronavirus 2019 Pandemic
https://doi.org/10.1097/jto.0000000000000659 Identifying Targeted Strategies to Improve Smoking Cessation Support for Cancer Patients
https://doi.org/10.1016/j.jtho.2017.05.019 Scientific Advances in Thoracic Oncology 2016
https://doi.org/10.1016/j.jtho.2023.07.019 Current and Future Perspectives on Computed Tomography Screening for Lung Cancer: A Roadmap From 2023 to 2027 From the International Association for the Study of Lung Cancer
https://doi.org/10.1158/1078-0432.ccr-23-0251 Multi-omics Analysis Reveals Immune Features Associated with Immunotherapy Benefit in Patients with Squamous Cell Lung Cancer from Phase III Lung-MAP S1400I Trial
https://doi.org/10.1016/j.jtho.2023.07.017 International Association for the Study of Lung Cancer Study of Reproducibility in Assessment of Pathologic Response in Resected Lung Cancers After Neoadjuvant Therapy
https://doi.org/10.1016/j.annonc.2024.10.006 Lung cancer research and treatment: global perspectives and strategic calls to action
https://doi.org/10.1016/j.jtho.2024.11.016 Differentiating Separate Primary Lung Adenocarcinomas From Intrapulmonary Metastases With Emphasis on Pathological and Molecular Considerations: Recommendations From the International Association for the Study of Lung Cancer Pathology Committee
https://doi.org/10.1016/j.ejca.2025.115264 Paradigm shift in early detection: Lung cancer screening to comprehensive CT screening
https://doi.org/10.1016/j.jtho.2025.05.024 Advances in Lung Cancer Basic and Translational Research in 2025 – Overview and Perspectives Focusing on NSCLC
https://doi.org/10.1016/j.jtho.2025.06.025 The International Association for the Study of Lung Cancer Staging Project: The Impact of Common Molecular Alterations on Overall Survival in NSCLC in Initial Analyses of the IASLC Ninth Edition Staging Database
https://doi.org/10.1016/j.jtho.2025.07.114 The 2024 International Association for the Study of Lung Cancer Global Survey on Biomarker Testing
https://doi.org/10.1016/j.jtho.2025.07.002 The International Association for the Study of Lung Cancer Staging Project: The Impact of Smoking Status on Lung Cancer Staging in the Ninth Edition of the TNM Classification
https://doi.org/10.3152/030234209x465552 Creativity: people, environment and culture, the key elements in its understanding and interpretation
https://doi.org/10.1200/jco.2012.42.7922 New Staging System: How Does It Affect Our Practice?
https://doi.org/10.1016/j.cllc.2016.05.003 Challenges in Facing the Lung Cancer Epidemic and Treating Advanced Disease in Latin America
https://doi.org/10.12788/jcso.0205 Impact of surgery for stage IA non-small-cell lung cancer on patient quality of life
https://doi.org/10.1016/j.jtho.2020.03.027 Lung Cancer Surgical Management During the Outbreak of Coronavirus Disease 2019
https://doi.org/10.1016/j.jtho.2020.12.026 The International Association for the Study of Lung Cancer Global Survey on Programmed Death-Ligand 1 Testing for NSCLC
https://doi.org/10.1016/j.jtho.2021.11.008 Lung Cancer Screening Considerations During Respiratory Infection Outbreaks, Epidemics or Pandemics: An International Association for the Study of Lung Cancer Early Detection and Screening Committee Report
https://doi.org/10.1038/s41467-023-40813-w Atezolizumab plus stereotactic ablative radiotherapy for medically inoperable patients with early-stage non-small cell lung cancer: a multi-institutional phase I trial
https://doi.org/10.1016/j.jtho.2023.08.016 The International Association for the Study of Lung Cancer Early Lung Imaging Confederation Open-Source Deep Learning and Quantitative Measurement Initiative
https://doi.org/10.1200/cci.19.00099 The International Association for the Study of Lung Cancer Early Lung Imaging Confederation
https://doi.org/10.1016/j.xjon.2023.11.003 Vascular invasion predicts the subgroup of lung adenocarcinomas ≤2.0 cm at risk of poor outcome treated by wedge resection compared to lobectomy
https://doi.org/10.32749/nucleodoconhecimento.com.br/saude/hpv Perfil epidemiológico do HPV da população feminina sexualmente ativa, na faixa etária de 10 a 80 anos
https://doi.org/10.1016/j.ejca.2025.115345 AI integrations with lung cancer screening: Considerations in developing AI in a public health setting
https://doi.org/10.1016/j.jtocrr.2024.100776 State of Lung Cancer in Egypt: Moving Towards Improved Guidelines for Prevention, Screening, Treatment, and Clinical Care Programs
https://doi.org/10.1016/j.jtocrr.2024.100738 S1701, A Randomized Phase 2 Trial of Carboplatin-Paclitaxel With and Without Ramucirumab in Patients With Locally Advanced, Recurrent, or Metastatic Thymic Carcinoma
https://doi.org/10.1016/j.jtho.2025.07.009 Molecular Tumor Boards: A Consensus Statement From the International Association for the Study of Lung Cancer
https://doi.org/10.1200/jco.2025.43.16_suppl.8541 Biomarker testing of lung cancer in North America versus globally.
https://doi.org/10.1200/jco.2025.43.16_suppl.8518 S1900E: A phase II study examining impact of co-mutations on sotorasib for previously treated stage IV/recurrent KRAS G12C mutated (MUT) non-squamous (Non-sq) non-small cell lung cancer (NSCLC) (ECOG-ACRIN led Lung-MAP Sub-study).
https://doi.org/10.1016/s0140-6736(25)01719-2 The IASLC–Lancet Commission: a transformative global approach to lung cancer
https://doi.org/10.1016/j.jtho.2025.09.1133 PT1.07.01 IASLC Multidisciplinary Recommendations for Pathological Response Evaluation of Resected Lymph Nodes After Neoadjuvant Therapy in NSCLC
https://doi.org/10.1016/j.esmoop.2025.106034 Global advances and future directions in lung cancer care: expert consensus and strategic priorities
https://doi.org/10.1002/1097-0142(19880901)62:5<973::aid-cncr2820620521>3.0.co;2-o Histopathologic classification of small cell lung cancer changing concepts and terminology
https://doi.org/10.1016/j.jtho.2018.08.247 OA03.03 Phase 2B of Blueprint PD-L1 Immunohistochemistry Assay Comparability Study
https://doi.org/10.1016/j.jtho.2018.02.020 “Teachable Moment” Interventions in Lung Cancer: Why Action Matters
https://doi.org/10.1016/j.cllc.2017.04.010 Access to Cancer Specialist Care and Treatment in Patients With Advanced Stage Lung Cancer
https://doi.org/10.1186/s13014-022-01994-8 Survival impact of prophylactic cranial irradiation in small-cell lung cancer in the modern era of magnetic resonance imaging staging
https://doi.org/10.1002/jcb.29564 From clinical specimens to human cancer preclinical models—a journey the NCI‐cell line database—25 years later
https://doi.org/10.4049/jimmunol.1701054 An Isolated TCR αβ Restricted by HLA-A*02:01/CT37 Peptide Redirecting CD8+ T Cells To Kill and Secrete IFN-γ in Response to Lung Adenocarcinoma Cell Lines
https://doi.org/10.1016/j.jtocrr.2023.100592 Natural History and Real-World Treatment Outcomes for Patients With NSCLC Having EGFR Exon 20 Insertion Mutation: An International Association for the Study of Lung Cancer–American Society of Clinical Oncology CancerLinQ Study
https://doi.org/10.1200/jco.2022.40.16_suppl.9128 Molecular testing and patterns of treatment in patients with NSCLC: An IASLC analysis of ASCO CancerLinQ Discovery Data.
https://doi.org/10.1016/j.jtho.2024.09.029 OA03.03 The 2024 International Association for the Study of Lung Cancer (IASLC) Global Survey on Biomarker Testing
https://doi.org/10.1158/1538-7445.am2014-5049 Abstract 5049: Physician preferences in tobacco cessation support for cancer patients: A survey of physicians at National Cancer Institute Designated Cancer Centers
https://doi.org/10.6058/jlc.2010.9.2.57 Female Lung Cancer: Re-Analysis of National Survey of Lung Cancer in Korea, 2005
https://doi.org/10.4081/mrm.2014.375 Audit on the appropriateness of integrated COPD management: the “ALT-BPCO” project
https://doi.org/10.1097/jto.0000000000000340 International Association for the Study of Lung Cancer (IASLC): Celebrating 40 Years with Scientific and Educational Achievements!
https://doi.org/10.1016/j.jtho.2019.08.675 MA21.03 The International Association for the Study of Lung Cancer (IASLC) Global Survey on Molecular Testing in Lung Cancer
https://doi.org/10.4081/mrm.2014.419 AIMAR survey on COPD phenotypes
https://doi.org/10.1016/j.jtho.2019.08.1673 P2.09-24 IASLC Global Survey for Pathologists on PD-L1 Testing for Non-Small Cell Lung Cancer
https://doi.org/10.1016/j.canep.2022.102210 Smoking cessation after a cancer diagnosis: Commentary on special supplement in Cancer Epidemiology
https://doi.org/10.1200/po.23.00677 CNS Antitumor Activity of Amivantamab With Osimertinib in Epidermal Growth Factor Receptor–Mutated Non–Small Cell Lung Cancer With Acquired Mesenchymal-Epithelial Transition Amplification Resistance Mechanism: A Case Report
https://doi.org/10.1016/j.cllc.2025.05.011 Baseline Characteristics of Participants and Pulmonary Nodules in the Watch the Spot Trial: A Pragmatic Trial of Less versus More Intensive Strategies for Active Surveillance of Patients With Small Pulmonary Nodules
https://doi.org/10.1016/j.jtho.2025.09.1761 A Grading System for Resected Invasive Squamous Cell Carcinoma of the Lung: A Multi-Institutional Study by the IASLC Pathology Committee
https://doi.org/10.1016/j.jacr.2025.10.010 Radiation Dose Associated With CT in the Watch the Spot Trial: A Pragmatic Trial of Less Versus More Intensive Strategies for Active Follow-Up of Patients With Small Pulmonary Nodules
https://doi.org/10.1016/j.jacr.2025.09.022 Less Versus More Intensive Surveillance of Pulmonary Nodules Detected Incidentally or by Screening: A Survey of Radiologist Beliefs About Guidelines Implemented in the Watch the Spot Trial
https://doi.org/10.2217/lmt-2017-0005 Lung Cancer Patient Needs in Different Countries
https://doi.org/10.1016/j.jtho.2021.08.533 P50.05 Natural History and Real-World Treatment Outcomes for NSCLC Patients with EGFR Exon 20 Insertion Mutation: An IASLC- ASCO CancerLinQ Study
https://doi.org/10.1007/978-88-470-2472-4_9 La trasmissione dell’attaccamento tra madre e figlio: Uno studio italiano
https://doi.org/10.3322/canjclin.8.2.71 II. What Can One Think?
https://doi.org/10.1097/jto.0000000000000121 An Era of Lung Cancer Iconoclasts
https://doi.org/10.1016/j.jtho.2016.11.1329 P2.03b-048 Access to Biomarker Testing in Patients with Advanced Non-Small Cell Lung Cancer
https://doi.org/10.1016/j.jtho.2019.01.012 Honoring the Past, Embracing the Present, You Are the Future
https://doi.org/10.1016/j.jtho.2021.06.005 New Pulmonary Infiltrates Observed on Computed Tomography-Based Image Guidance for Radiotherapy Warrant Diagnostic Workup for Coronavirus Disease 2019
https://doi.org/10.1016/j.jtho.2021.08.093 OA17.04 The Global Impact of COVID-19 on Telehealth and Care for Persons With Thoracic Cancers
https://doi.org/10.3233/acs-2009-17102 Irish Association of Speech and Language Therapists
https://doi.org/10.2482/haigan.43.259 Frequency of Brain Metastasis in Lung Cancer at the Time of Diagnosis.
https://doi.org/10.1053/sonc.2002.34265 Expression of target molecules in lung cancer: Challenge for a new treatment paradigm
https://doi.org/10.1093/jnci/djn082 Diseases Desperate Grown
https://doi.org/10.1016/s1556-0864(15)31504-5 International Association for the Study of Lung Cancer: The First Three Decades
https://doi.org/10.5204/thesis.eprints.127346 Targeting the Nuclear Factor Kappa-Light-Chain-Enhancer of Activated B Cells (NF-kB) Pathway to Overcome Cisplatin-Resistance in Non-Small Cell Lung Cancer
https://doi.org/10.1007/bf01576347 Trauma of the torso and the urogenital tract in Alpine skiiers
https://doi.org/10.1016/j.lungcan.2014.03.014 “What is in a name? That which we call a rose. By any other name would smell as sweet”: Towards resolving ambiguity in the TNM Classification for Lung Cancer
https://doi.org/10.1200/jco.2014.32.15_suppl.e17508 Addressing findings from the 2014 Surgeon General’s Report: Physician preference for supporting tobacco cessation in cancer patients.
https://doi.org/10.1016/j.jtho.2017.09.262 MS 19.02 Lung Cancer Awareness Month: Unity through IASLC – Organizer Perspective